Roivant Sciences Ltd. Common Shares (ROIV) — Analysis Summary

Roivant Sciences Ltd. Common Shares (ROIV) has a market cap of $21.60B with year-over-year revenue growth of -71.6%. Net margin stands at -3629.2%. The stock trades at a P/E ratio of -72.1.

Key Takeaways

• Revenue changed -71.6% year-over-year
• Net margin of -3629.2%
• P/E ratio of -72.1

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, ROIV posted revenue growth of -71.6% and trades at a P/E of -72.1.